Clinical Trial Update: Sirolimus in Treating Patients With Glioblastoma Multiforme [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for sirolimus in patients with glioblastoma multiforme spanning Phase 1 and Phase 2, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED